Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001753763-19-000001)

Filing Details

Accession Number:: 0001753763-19-000001
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-03-25 17:36:11
Reporting Period:: 2019-03-22

Accepted Time:: 2019-03-25 17:36:11
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
810509	Navidea Biopharmaceuticals Inc.	NAVB	In Vitro & In Vivo Diagnostic Substances (2835)	311080091

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1753763	Jr. K John Scott	5251 Dtc Parkway, Suite 285 Greenwood Village CO 80111		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-03-22	357,143	$0.14	22,261,565	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	52,785	Indirect	By Spouse
Common Stock	50,000	Indirect	By Daughter
Common Stock	50,000	Indirect	By Son
Common Stock	50,000	Indirect	By Son

Footnotes

The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.